☆ 4.7 Article

A Case Report of Pediatric Patient with Tuberous Sclerosis and Radiologically Isolated Syndrome

JOURNAL OF CLINICAL MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Letter Clinical Neurology

Concurrent diagnoses of Tuberous sclerosis and multiple sclerosis

Suzanne Quigley et al.

Summary: Tuberous sclerosis (TS) is a monogenic disorder that causes neurological symptoms, while multiple sclerosis (MS) can also result in disability but is diagnosed without genetic testing. Clinicians should be cautious in diagnosing MS when there is a pre-existing genetic disorder, as it may raise a potential red flag. This is the first report of dual diagnosis of TS and MS in the literature, with two cases presenting new neurological symptoms and physical signs compatible with TS/MS dual diagnosis.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2023)

添加到收藏夹

Review Behavioral Sciences

Genetic pathogenesis of the epileptogenic lesions in Tuberous Sclerosis Complex: Therapeutic targeting of the mTOR pathway

Romina Moavero et al.

Summary: Tuberous sclerosis complex (TSC) is a genetic disease that affects multiple organs and systems, with a high risk of early onset and refractory seizures. The overactivation of the mammalian Target of Rapamycin (mTOR) complex is the main cause of TSC-related manifestations. mTOR inhibitors such as rapamycin and everolimus have shown potential in suppressing seizures and preventing epilepsy development in animal models. Everolimus has been approved for the treatment of refractory seizures associated with TSC, with better efficacy in younger children. Early suppression of abnormal mTOR signaling with mTOR inhibitors may be a more effective approach in treating TSC-related epilepsy.

EPILEPSY & BEHAVIOR (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data

Aigli G. Vakrakou et al.

Summary: This article summarizes the evidence on the role of mammalian targets of rapamycin (mTOR) complex pathways in multiple sclerosis (MS), including autophagy, inflammasome activation, immune responses, and neuronal toxicity. There is robust evidence that mTOR inhibitors, such as rapamycin, improve the clinical course of MS animal models. New research highlights the effects of mTOR on T cells and myeloid cells, providing insight into MS pathogenesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Clinical Neurology

Advances in the genetics and neuropathology of tuberous sclerosis complex: edging closer to targeted therapy

Paolo Curatolo et al.

LANCET NEUROLOGY (2022)

添加到收藏夹

Article Cell Biology

Hyperactivation of mTORC1 in a double hit mutant zebrafish model of tuberous sclerosis complex causes increased seizure susceptibility and neurodevelopmental abnormalities

Ann-Sofie De Meulemeester et al.

Summary: TSC is a genetic disorder caused by mutations in TSC1 and TSC2 genes. A double mutant zebrafish model was used to study the disease, and it was found that the double mutants had a more severe phenotype and could be rescued by rapamycin. The transcriptome of the double mutant zebrafish larvae strongly overlapped with human SEGA lesions.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Disrupted white matter connectivity and organization of brain structural connectomes in tuberous sclerosis complex patients with neuropsychiatric disorders using diffusion tensor imaging

Jeng-Dau Tsai et al.

Summary: The study evaluated the diffusion characteristics, white matter lesions, and brain structural network alterations in patients with tuberous sclerosis complex (TSC), finding a correlation between diffusion parameters in tubers and neurological severity, and more structural network disruptions in patients with intellectual disability (ID), seizures, and higher severity of neurological symptoms.

MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2021)

添加到收藏夹

Review Clinical Neurology

What does first-line therapy mean for paediatric multiple sclerosis in the current era?

Yael Hacohen et al.

Summary: Pediatric multiple sclerosis presents with unique characteristics compared to adult-onset disease, requiring treatment strategies tailored to the clinical manifestations and risks of pediatric MS. It is recommended to treat pediatric MS as a highly active disease, favoring the early use of highly effective DMTs rather than injectable DMTs.

MULTIPLE SCLEROSIS JOURNAL (2021)

添加到收藏夹

Article Clinical Neurology

Fingolimod in pediatric multiple sclerosis: three case reports

Michela Ada Noris Ferilli et al.

Summary: This paper presents three case histories of pediatric-onset multiple sclerosis patients and highlights the different uses of fingolimod in treatment, including escalation therapy and first-choice therapy. In all three cases, there was no further disease progression and no adverse events recorded approximately 1 year after initiating fingolimod treatment.

NEUROLOGICAL SCIENCES (2021)

添加到收藏夹

Article Clinical Neurology

Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations

Hope Northrup et al.

Summary: The diagnostic criteria and management recommendations for tuberous sclerosis complex (TSC) were revised in 2018 based on advancements in knowledge and new therapies since 2013. Changes were made mainly to clinical and genetic diagnostic criteria, as well as surveillance and management standards. These updates aim to provide an improved care framework for individuals with TSC and their families.

PEDIATRIC NEUROLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Novel Insights for Multiple Sclerosis and Demyelinating Disorders with Apoptosis, Autophagy, FoxO, and mTOR

Kenneth Maiese

CURRENT NEUROVASCULAR RESEARCH (2021)

添加到收藏夹

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

添加到收藏夹

Article Clinical Neurology

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations

Nicola De Stefano et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

添加到收藏夹

Article Clinical Neurology

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations

Nicola De Stefano et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

添加到收藏夹

Review Clinical Neurology

Radiologically isolated syndrome in children: Current knowledge and future directions

Colin Wilbur et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)

添加到收藏夹

Article Neurosciences

Corpus Callosum White Matter Diffusivity Reflects Cumulative Neurological Comorbidity in Tuberous Sclerosis Complex

Fiona M. Baumer et al.

CEREBRAL CORTEX (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway

Huiqing Hou et al.

NEUROCHEMICAL RESEARCH (2017)

添加到收藏夹

Letter Medicine, General & Internal

Incidental Findings on Brain Imaging in the General Pediatric Population

Philip R. Jansen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Clinical Neurology

Radiologically isolated syndrome in children: Clinical and radiologic outcomes

Naila Makhani et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)

添加到收藏夹

Review Biochemistry & Molecular Biology

mTOR Signaling in Growth, Metabolism, and Disease

Robert A. Saxton et al.

CELL (2017)

添加到收藏夹

Article Behavioral Sciences

White matter disruption is associated with persistent seizures in tuberous sclerosis complex

Romina Moavero et al.

EPILEPSY & BEHAVIOR (2016)

添加到收藏夹

Review Clinical Neurology

Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC

Paolo Curatolo et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2016)

添加到收藏夹

Review Clinical Neurology

Neurological and neuropsychiatric aspects of tuberous sclerosis complex

Paolo Curatolo et al.

LANCET NEUROLOGY (2015)

添加到收藏夹

Review Clinical Neurology

Genotype/Phenotype Correlations in Tuberous Sclerosis Complex

Paolo Curatolo et al.

SEMINARS IN PEDIATRIC NEUROLOGY (2015)

添加到收藏夹

Review Immunology

Immunopathology of multiple sclerosis

Calliope A. Dendrou et al.

NATURE REVIEWS IMMUNOLOGY (2015)

添加到收藏夹

Article Clinical Neurology

Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season

Grant P. Parnell et al.

MULTIPLE SCLEROSIS JOURNAL (2014)

添加到收藏夹

Article Clinical Neurology

mTOR Its role in the nervous system and involvement in neurologic disease

Nicholas D. Child et al.

NEUROLOGY (2014)

添加到收藏夹

Article Clinical Neurology

The neuroanatomical phenotype of tuberous sclerosis complex: focus on radial migration lines

Agnies M. van Eeghen et al.

NEURORADIOLOGY (2013)

添加到收藏夹

Review Pediatrics

Is mTOR inhibition a systemic treatment for tuberous sclerosis?

Romina Moavero et al.

ITALIAN JOURNAL OF PEDIATRICS (2013)

添加到收藏夹

Review Biochemistry & Molecular Biology

mTOR: A pathogenic signaling pathway in developmental brain malformations

Peter B. Crino

TRENDS IN MOLECULAR MEDICINE (2011)

添加到收藏夹

Review Clinical Neurology

Recent advances in neurobiology of Tuberous Sclerosis Complex

Valerio Napolioni et al.

BRAIN & DEVELOPMENT (2009)

添加到收藏夹

Article Clinical Neurology

Incidental MRI anomalies suggestive of multiple sclerosis The radiologically isolated syndrome

D. T. Okuda et al.

NEUROLOGY (2009)

添加到收藏夹

Review Medicine, General & Internal

Tuberous sclerosis

Paolo Curatolo et al.

LANCET (2008)

添加到收藏夹

Article Clinical Neurology

Characteristics of abnormal diffusivity in normal-appearing white matter investigated with diffusion tensor MR imaging in tuberous sclerosis complex

M. I. Makki et al.

AMERICAN JOURNAL OF NEURORADIOLOGY (2007)

添加到收藏夹

Article Medicine, General & Internal

Natural history of multiple sclerosis with childhood onset

Christel Renoux et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.